Outcome | Assessment points a | Assessments | Women | Mean b |
---|---|---|---|---|
N | N | |||
Malaria parasite +ve | ANC1, FIN | 1287 | 1230 | 578 (44.9) |
Antimalarial Px rate/year | Weekly visits | 102,452 c | 1897 | 2120 (2.1) |
Antibiotic Px rate/year | Weekly visits | 102,452 c | 1897 | 1287 (1.3) |
Abnormal vaginal flora +ve | Baseline, ANC1, FIN | 2397 | 1683 | 505 (21.1) |
Chorioamnionitis +ve | Delivery | 181 | 181 | 80 (44.2) |
BIS, mg/kg | Baseline, ANC1, FIN | 2594 | 1757 | 5.5 (2.8–7.6) |
Hepcidin, nmol/l | Baseline, ANC1, FIN | 2923 | 1885 | 3.8 (1.6–8.7) |
sTfR, μg/ml | Baseline, ANC1, FIN | 2923 | 1881 | 6.2 (5.0–7.8) |
Lf, μg/ml | ANC1, FIN | 1048 | 999 | 9.85 (2.85–61.17) |
CRP, mg/l | Baseline, ANC1, FIN | 2926 | 1884 | 0.631 (0.224–1.937) |
MUAC, cms | Baseline, ANC1, FIN | 2956 | 1898 | 24.1 (22.9–25.4) |
BMI, kg/m2 | Baseline, ANC1, FIN | 2956 | 1897 | 20.2 (19.0–21.6) |